PubRank

Stéphane Richard

Author PubWeight™ 160.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Arginine methylation an emerging regulator of protein function. Mol Cell 2005 6.49
2 Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 2005 3.70
3 Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol 2009 3.60
4 A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011 3.53
5 Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005 3.20
6 RNA-binding proteins in human genetic disease. Trends Genet 2008 3.14
7 An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 2011 2.78
8 A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics 2003 2.59
9 PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 2008 2.56
10 von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011 2.45
11 Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010 2.43
12 RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J 2012 2.34
13 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005 2.26
14 Tudor domains bind symmetrical dimethylated arginines. J Biol Chem 2005 2.23
15 Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006 2.23
16 Sam68, the KH domain-containing superSTAR. Biochim Biophys Acta 2003 2.08
17 Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 2005 2.02
18 Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol Biol Cell 2003 1.87
19 New implications for the QUAKING RNA binding protein in human disease. J Neurosci Res 2008 1.71
20 The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol 2009 1.70
21 Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 2013 1.69
22 Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 2004 1.62
23 Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev 2005 1.61
24 SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 2011 1.60
25 Defining the RGG/RG motif. Mol Cell 2013 1.59
26 Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem 2005 1.47
27 The formin homology 1 domain modulates the actin nucleation and bundling activity of Arabidopsis FORMIN1. Plant Cell 2005 1.46
28 Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol 2003 1.42
29 Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 2002 1.41
30 A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 2009 1.40
31 Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005 1.39
32 Inactivation of BHD in sporadic renal tumors. Cancer Res 2003 1.36
33 The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. J Biol Chem 2004 1.36
34 Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis. J Cell Biol 2009 1.36
35 Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 2004 1.35
36 Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci 2002 1.33
37 Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 2007 1.31
38 The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 2005 1.30
39 Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Hum Mol Genet 2011 1.27
40 Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet 2008 1.20
41 The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis. Mol Cell 2012 1.19
42 Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat 2013 1.18
43 Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res 2008 1.17
44 The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res 2009 1.15
45 Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 2011 1.14
46 JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep 2012 1.14
47 The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol Biol Cell 2002 1.14
48 Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 2004 1.13
49 A glycine-arginine domain in control of the human MRE11 DNA repair protein. Mol Cell Biol 2008 1.13
50 Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 2009 1.12
51 The STAR RNA binding proteins GLD-1, QKI, SAM68 and SLM-2 bind bipartite RNA motifs. BMC Mol Biol 2009 1.11
52 PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA. Retrovirology 2006 1.10
53 Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 2014 1.09
54 Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res 2005 1.09
55 An improved method to determine serine palmitoyltransferase activity. J Lipid Res 2009 1.09
56 Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 2010 1.08
57 Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res 2012 1.07
58 Letter to the editor: Pregnancy and von Hippel-Lindau disease. J Neurosurg 2013 1.07
59 Motor coordination defects in mice deficient for the Sam68 RNA-binding protein. Behav Brain Res 2008 1.07
60 Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis 2014 1.06
61 Methylation of MRE11 regulates its nuclear compartmentalization. Cell Cycle 2005 1.06
62 Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 2010 1.06
63 Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer 2008 1.05
64 Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 2009 1.04
65 Vitreoretinal surgery for severe retinal capillary hemangiomas in von hippel-lindau disease. Ophthalmology 2011 1.04
66 Natural history of supratentorial hemangioblastomas in von Hippel-Lindau disease. Neurosurgery 2010 1.03
67 QUAKING KH domain proteins as regulators of glial cell fate and myelination. RNA Biol 2005 1.02
68 Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4. Biochem J 2004 1.00
69 Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Mol Cell Biol 2008 1.00
70 An adaptor role for cytoplasmic Sam68 in modulating Src activity during cell polarization. Mol Cell Biol 2009 0.99
71 Sam68 marks the transcriptionally active stages of spermatogenesis and modulates alternative splicing in male germ cells. Nucleic Acids Res 2011 0.99
72 The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation. Cell Res 2011 0.99
73 Real-time PCR to identify variola virus or other human pathogenic orthopox viruses. Clin Chem 2007 0.98
74 BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest. Cell Signal 2009 0.98
75 Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. Circ Res 2013 0.95
76 Arginine methylation signals mRNA export. Nat Struct Mol Biol 2004 0.95
77 Depolarization-induced translocation of the RNA-binding protein Sam68 to the dendrites of hippocampal neurons. J Cell Sci 2004 0.95
78 Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates. Epigenetics 2010 0.94
79 Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function. AIDS 2007 0.94
80 Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration. Cell Signal 2007 0.93
81 The QKI-5 and QKI-6 RNA binding proteins regulate the expression of microRNA 7 in glial cells. Mol Cell Biol 2013 0.93
82 Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Haematologica 2011 0.92
83 Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation. J Biol Chem 2011 0.91
84 Calcium-dependent deceleration of the cell cycle in muscle cells by simulated microgravity. FASEB J 2013 0.90
85 Conservative management of endolymphatic sac tumors in von Hippel-Lindau disease: case report. Acta Neurochir (Wien) 2010 0.90
86 Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place. Ann Surg 2015 0.90
87 Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells. Nat Commun 2013 0.90
88 Lectin-like Ox-LDL receptor is expressed in human INT-407 intestinal cells: involvement in the transcytosis of pancreatic bile salt-dependent lipase. Mol Biol Cell 2003 0.90
89 Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients. Clin Cancer Res 2012 0.90
90 No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome. Fam Cancer 2010 0.89
91 Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 2010 0.88
92 Identification of a Sam68 ribonucleoprotein complex regulated by epidermal growth factor. J Biol Chem 2009 0.87
93 Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 2007 0.87
94 Targeting the RNA-binding protein Sam68 as a treatment for cancer? Future Oncol 2007 0.87
95 The QKI-6 RNA binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte differentiation. Mol Biol Cell 2010 0.87
96 The QKI-6 RNA binding protein localizes with the MBP mRNAs in stress granules of glial cells. PLoS One 2010 0.86
97 The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination. PLoS One 2009 0.85
98 SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal. Epigenetics 2013 0.85
99 Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. Pancreas 2008 0.85
100 The association of Sam68 with Vav1 contributes to tumorigenesis. Cell Signal 2007 0.84
101 Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol 2009 0.84
102 mRNAs associated with the Sam68 RNA binding protein. RNA Biol 2006 0.83
103 K48-linked ubiquitination and protein degradation regulate 53BP1 recruitment at DNA damage sites. Cell Res 2012 0.83
104 Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases. Otol Neurotol 2010 0.82
105 Novel somatic mutations of the VHL gene in an erythropoietin-producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells. Am J Hematol 2008 0.82
106 Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival. Sci Rep 2011 0.82
107 Spectrum of abdominal imaging findings in von Hippel-Lindau disease. AJR Am J Roentgenol 2003 0.81
108 The role of arginine methylation in the DNA damage response. DNA Repair (Amst) 2013 0.80
109 Patched1 haploinsufficiency impairs ependymal cilia function of the quaking viable mice, leading to fatal hydrocephalus. Mol Cell Neurosci 2011 0.80
110 Emerging roles for Sam68 in adipogenesis and neuronal development. RNA Biol 2012 0.80
111 Difficult diagnosis of atypical cystic pancreatic lesions in von Hippel-Lindau disease. J Comput Assist Tomogr 2010 0.79
112 A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma. Mutat Res 2008 0.79
113 Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas. Carcinogenesis 2013 0.79
114 Arginine methylation regulates the cytokine response. Mol Cell 2004 0.79
115 High incidence of renal tumours in vitamins A and E synthesis workers: a new cause of occupational cancer? Int J Cancer 2004 0.79
116 Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol 2011 0.79
117 Enhanced robustness digital holographic microscopy for demanding environment of space biology. Biomed Opt Express 2012 0.79
118 Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease. Otol Neurotol 2014 0.78
119 Accelerated autofocusing of off-axis holograms using critical sampling. Opt Lett 2012 0.78
120 Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1. Mol Biol Cell 2014 0.78
121 The fight of the Tudor domain "Royal family" for a broken DNA throne. Cell Cycle 2012 0.77
122 Supratentorial hemangioblastoma in the neonatal period. Pediatr Neurosurg 2009 0.76
123 Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy. Ann Endocrinol (Paris) 2012 0.76
124 Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2015 0.75
125 Stay lean without dieting: Lose Sam68. Adipocyte 2012 0.75
126 Radiology quiz case. Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease. Arch Otolaryngol Head Neck Surg 2002 0.75
127 Diagnosis of pheochromocytoma and laparoscopic adrenalectomy in two anephric patients with von Hippel-Lindau disease. Am J Kidney Dis 2002 0.75
128 [A new role for arginine methylation in DNA repair]. Med Sci (Paris) 2005 0.75
129 [Hereditary renal cell carcinoma: results and place of conventional conservative surgery]. Prog Urol 2003 0.75
130 Biphasic Squamoid Alveolar Renal Cell Carcinoma: 2 Cases in a Family Supporting a Continuous Spectrum With Papillary Type I Renal Cell Carcinoma. Am J Surg Pathol 2017 0.75